Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

Thalgott M.; Heck M. M.; Eiber M.; Souvatzoglou M.; Hatzichristodoulou G.; Kehl V.; Krause B. J.; Rack B.; Retz M.; Gschwend J. E.; Andergassen U.; Nawroth R.

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

【24h】

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

机译：循环肿瘤细胞与客观反应评估评估多西他赛化疗治疗的转移性去势抵抗性前列腺癌患者的生存

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose Circulating tumor cell (CTC) counts might display a superior prognostic value for overall survival (OS) compared to objective response criteria (OR) in metastatic castration-resistant prostate cancer (mCRPC) patients.

机译：目的与转移性去势抵抗性前列腺癌（mCRPC）患者相比，循环肿瘤细胞（CTC）计数相对于客观应答标准（OR）可能显示出更好的预后价值。

著录项

来源
《Journal of Cancer Research and Clinical Oncology 》 |2015年第8期| 共8页
作者
Thalgott M.; Heck M. M.; Eiber M.; Souvatzoglou M.; Hatzichristodoulou G.; Kehl V.; Krause B. J.; Rack B.; Retz M.; Gschwend J. E.; Andergassen U.; Nawroth R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词
Biomarkers; Circulating tumor cells; CTCs; Objective response; Prostate cancer; Surrogate marker;

机译：生物标志物;循环肿瘤细胞;CTC;客观反应;前列腺癌;替代标志物;

相似文献

外文文献
中文文献
专利

1. Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy [J] . Thalgott M., Heck M. M., Eiber M., Journal of Cancer Research and Clinical Oncology . 2015 ,第8期

机译：循环肿瘤细胞与客观反应评估评估多西他赛化疗治疗的转移性去势抵抗性前列腺癌患者的生存
2. Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? Reply [J] . Antonarakis Emmanuel S. Journal of Clinical Oncology . 2018 ,第22期

机译：循环肿瘤细胞数作为转移阉割前列腺癌的长期存活的响应量度：是优于前列腺特异性抗原的真实循环肿瘤细胞数吗？回复
3. Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: Is Real Circulating Tumor Cell Number Superior to Prostate-Specific Antigen? [J] . Ren Chuanli, Han Chongxu, Wang Daxin, Journal of Clinical Oncology . 2018 ,第22期

机译：循环肿瘤细胞数作为转移阉割前列腺癌的长期存活的响应量度：是优于前列腺特异性抗原的真实循环肿瘤细胞数吗？
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. Comparative Analysis on Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells [D] . Santos, Mark Anthony Francisco. 2014

机译：转移性乳腺癌，结直肠癌和前列腺癌患者循环肿瘤细胞先天免疫系统功能的比较分析
6. Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy [O] . Takatsugu Okegawa, Naoshi Itaya, Hidehiko Hara, 2016

机译：多西他赛化疗治疗去势抵抗型前列腺癌患者中循环肿瘤细胞中表皮生长因子受体状态作为敏感性的预测生物标志物
7. Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy [O] . Takatsugu Okegawa, Naoshi Itaya, Hidehiko Hara, 2016

机译：循环肿瘤细胞中的表皮生长因子受体状态作为多西紫杉醇化疗治疗去势抵抗性前列腺癌患者敏感性的预测生物标志物

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅